ID: ALA4291177

Max Phase: Preclinical

Molecular Formula: C22H21N3O3

Molecular Weight: 375.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1c2cc(-c3ccccc3)n(-c3ccccc3)c2ncn1CCOCCO

Standard InChI:  InChI=1S/C22H21N3O3/c26-12-14-28-13-11-24-16-23-21-19(22(24)27)15-20(17-7-3-1-4-8-17)25(21)18-9-5-2-6-10-18/h1-10,15-16,26H,11-14H2

Standard InChI Key:  XCGPRORKPGDSQX-UHFFFAOYSA-N

Associated Targets(non-human)

unidentified influenza virus 265 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 375.43Molecular Weight (Monoisotopic): 375.1583AlogP: 2.86#Rotatable Bonds: 7
Polar Surface Area: 69.28Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.47CX LogP: 2.83CX LogD: 2.83
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.05

References

1. Pathania S, Rawal RK..  (2018)  Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.,  157  [PMID:30114661] [10.1016/j.ejmech.2018.08.023]

Source